Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Breast Neoplasms 4Leukemia 3Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Myelodysplastic Syndromes 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Imatinib Mesylate 17Dasatinib 8nilotinib 7Cytarabine 5Hydroxyurea 4ponatinib 3Peripheral Blood Stem Cell Transplantation 3Interferon-alpha 3bosutinib 2Surveys and Questionnaires 2Stem Cell Transplantation 2Radiotherapy 2Polymerase Chain Reaction 2Pioglitazone 2Idarubicin 2Cytogenetic Analysis 2Busulfan 2Antilymphocyte Serum 2thymoglobulin 1peginterferon alfa-2a 1flumatinib 1fludarabine phosphate 1Tyrosine Kinase Inhibitors 1Therapeutics 1Registries 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1PF-114 1Mycophenolic Acid 1Mitoxantrone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Cytogenetic Analysis × Clear all
NCT01004640 2023-09-14

Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial

Alliance for Clinical Trials in Oncology

Unknown
60 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01227135 2011-11-30

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

University of Glasgow

Phase 2 Unknown
66 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡